This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cigna And SAICO Announce Joint Venture Agreement To Further Extend Its Partnership And Offerings Across Middle East

The Global Health Benefits business unit of Cigna (NYSE:CI) and Saudi Arabian Insurance Company B.S.C (C) (SAICO) today announced they signed a joint-venture agreement to enhance their current partnership in developing their portfolio of health, wellness and insurance products targeted to regional and multi-national employers and organizations across the Middle East, expanding the 11-year business relationship between these two companies.

“The Middle East is an important part of Cigna’s global growth strategy, and the new joint venture demonstrates our deepening commitment to investing in the region. We want to deepen our commitment to serving the local population as well as the globally mobile workforce on assignment in the region,” said Andrew Kielty, President of Cigna Global Health Benefits. “SAICO is a well-regarded general insurance company in the region and in partnership together, we have developed a solid reputation in the marketplace through our collective strength and focus, market knowledge, vast network and combined service proposition.”

“The Middle East is the primary market for SAICO’s operation where the medical business is one of the fastest growing areas for the company. SAICO is committed to servicing clients in the health insurance business as it does in other insurance lines. The joint venture combines the strengths of our two organizations and aligns the current partnership around a common goal of meeting the needs of customers and clients located in the Middle East for enhanced customer service and efficiency. In this partnership with Cigna, SAICO will be able to improve on cost containment through clinical and claims management,” said Nagib Bahous, President and CEO of SAICO.

Cigna and SAICO each will own half of the joint venture partnership. The JV partnership is committed to continuing to invest, growing further its product offerings and service capabilities in the Middle East and gaining market share in this geography.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs